John Richard Pinion - Net Worth and Insider Trading
John Richard Pinion Net Worth
The estimated net worth of John Richard Pinion is at least $4 Million dollars as of 2024-11-13. John Richard Pinion is the See Remarks of Ultragenyx Pharmaceutical Inc and owns about 89,268 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $4 Million. Details can be seen in John Richard Pinion's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Richard Pinion has not made any transactions after 2024-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Richard Pinion
John Richard Pinion Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Richard Pinion owns 1 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) .
Click here to see the complete history of John Richard Pinion’s form 4 insider trades.
Insider Ownership Summary of John Richard Pinion
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2024-03-01 | See Remarks |
John Richard Pinion Latest Holdings Summary
John Richard Pinion currently owns a total of 1 stock. John Richard Pinion owns 89,268 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 1, 2024, with a value of $4 Million.
Latest Holdings of John Richard Pinion
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2024-03-01 | 89,268 | 48.63 | 4,341,103 |
Holding Weightings of John Richard Pinion
John Richard Pinion Form 4 Trading Tracker
According to the SEC Form 4 filings, John Richard Pinion has made a total of 9 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 4,173 shares on March 1, 2024, which brought John Richard Pinion around $224,340.
Insider Trading History of John Richard Pinion
- 1
John Richard Pinion Trading Performance
John Richard Pinion Ownership Network
Ownership Network List of John Richard Pinion
Ownership Network Relation of John Richard Pinion
John Richard Pinion Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
John Richard Pinion is the See Remarks of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include Chief Financial Officer Howard Horn , director & 10 percent owner & President & CEO Emil D Kakkis , and Controller and PAO Theodore Alan Huizenga .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, John Richard Pinion made 2 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 6,185. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .
In summary, during the past 3 months, insiders sold 27,556 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 27,556 shares. During the past 18 months, 260,421 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 260,421 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
John Richard Pinion Mailing Address
Above is the net worth, insider trading, and ownership report for John Richard Pinion. You might contact John Richard Pinion via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.